Is Mettler-Toledo Stock Underperforming the Nasdaq?
Mettler-Toledo (MTD), a $25.9B diagnostics and research company, saw its stock reach a 52-week high of $1525.17 but has since fallen 15.1%. It outperformed the Nasdaq Composite over the past three months but lagged over the past year. MTD's Q2 2026 revenue was $1B, with adjusted EPS of $11.46, beating estimates. The company raised its full-year EPS guidance to $47.33. Analysts have a 'Moderate Buy' consensus rating with a mean price target of $1,464.60, implying 13.7% upside.


